265 related articles for article (PubMed ID: 30777937)
1. Stem cell-derived tissue-associated regulatory T cells suppress the activity of pathogenic cells in autoimmune diabetes.
Haque M; Lei F; Xiong X; Das JK; Ren X; Fang D; Salek-Ardakani S; Yang JM; Song J
JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30777937
[TBL] [Abstract][Full Text] [Related]
2. Targeting Stem Cell-Derived Tissue-Associated Regulatory T Cells for Type 1 Diabetes Immunotherapy.
Haque M; Das JK; Xiong X; Song J
Curr Diab Rep; 2019 Aug; 19(10):89. PubMed ID: 31471667
[TBL] [Abstract][Full Text] [Related]
3. Stem cell-derived tissue-associated regulatory T cells ameliorate the development of autoimmunity.
Haque M; Song J; Fino K; Sandhu P; Song X; Lei F; Zheng S; Ni B; Fang D; Song J
Sci Rep; 2016 Feb; 6():20588. PubMed ID: 26846186
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T cells prevent transfer of type 1 diabetes in NOD mice only when their antigen is present in vivo.
Tonkin DR; He J; Barbour G; Haskins K
J Immunol; 2008 Oct; 181(7):4516-22. PubMed ID: 18802054
[TBL] [Abstract][Full Text] [Related]
5. Targeting CD44 augments the efficacy of Tregs in autoimmune diabetes.
Li CR; Mueller EE; Bradley LM
Immunol Lett; 2015 Feb; 163(2):199-205. PubMed ID: 25447401
[TBL] [Abstract][Full Text] [Related]
6. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
[TBL] [Abstract][Full Text] [Related]
7. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.
Brode S; Raine T; Zaccone P; Cooke A
J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572
[TBL] [Abstract][Full Text] [Related]
8. IL-7 uniquely maintains FoxP3(+) adaptive Treg cells that reverse diabetes in NOD mice via integrin-β7-dependent localization.
Li CR; Deiro MF; Godebu E; Bradley LM
J Autoimmun; 2011 Nov; 37(3):217-27. PubMed ID: 21745722
[TBL] [Abstract][Full Text] [Related]
9. Proinsulin-specific T regulatory cells may control immune responses in type 1 diabetes: implications for adoptive therapy.
Gliwiński M; Iwaszkiewicz-Grześ D; Wołoszyn-Durkiewicz A; Tarnowska M; Żalińska M; Hennig M; Zielińska H; Dukat-Mazurek A; Zielkowska-Dębska J; Zieliński M; Jaźwińska-Curyłło A; Owczuk R; Jarosz-Chobot P; Bossowski A; Szadkowska A; Młynarski W; Marek-Trzonkowska N; Moszkowska G; Siebert J; Myśliwiec M; Trzonkowski P
BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32098895
[TBL] [Abstract][Full Text] [Related]
10. Stem Cell-Derived Viral Antigen-Specific T Cells Suppress HIV Replication and PD-1 Expression on CD4+ T Cells.
Haque M; Lei F; Xiong X; Ren Y; Peng HY; Wang L; Kumar A; Das JK; Song J
Viruses; 2021 Apr; 13(5):. PubMed ID: 33923025
[TBL] [Abstract][Full Text] [Related]
11. Emerging Therapeutic Strategies to Restore Regulatory T Cell Control of Islet Autoimmunity in Type 1 Diabetes.
Volfson-Sedletsky V; Jones A; Hernandez-Escalante J; Dooms H
Front Immunol; 2021; 12():635767. PubMed ID: 33815387
[TBL] [Abstract][Full Text] [Related]
12. Development of Auto Antigen-specific Regulatory T Cells for Diabetes Immunotherapy.
Song J
Immune Netw; 2016 Oct; 16(5):281-285. PubMed ID: 27799873
[TBL] [Abstract][Full Text] [Related]
13. Harnessing memory adaptive regulatory T cells to control autoimmunity in type 1 diabetes.
Li CR; Baaten BJ; Bradley LM
J Mol Cell Biol; 2012 Feb; 4(1):38-47. PubMed ID: 22116888
[TBL] [Abstract][Full Text] [Related]
14. Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice.
Amatya C; Radichev IA; Ellefson J; Williams M; Savinov AY
Mol Ther; 2018 Jan; 26(1):184-198. PubMed ID: 28988715
[TBL] [Abstract][Full Text] [Related]
15. Paralytic autoimmune myositis develops in nonobese diabetic mice made Th1 cytokine-deficient by expression of an IFN-gamma receptor beta-chain transgene.
Serreze DV; Pierce MA; Post CM; Chapman HD; Savage H; Bronson RT; Rothman PB; Cox GA
J Immunol; 2003 Mar; 170(5):2742-9. PubMed ID: 12594305
[TBL] [Abstract][Full Text] [Related]
16. Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity.
Haque M; Fino K; Sandhu P; Song J
J Vis Exp; 2016 Nov; (117):. PubMed ID: 27911371
[TBL] [Abstract][Full Text] [Related]
17. Altered homeostasis and development of regulatory T cell subsets represent an IL-2R-dependent risk for diabetes in NOD mice.
Dwyer CJ; Bayer AL; Fotino C; Yu L; Cabello-Kindelan C; Ward NC; Toomer KH; Chen Z; Malek TR
Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259102
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic regulatory T cells subvert effector T cell function in inflamed islets to halt autoimmune diabetes.
Mahne AE; Klementowicz JE; Chou A; Nguyen V; Tang Q
J Immunol; 2015 Apr; 194(7):3147-55. PubMed ID: 25732730
[TBL] [Abstract][Full Text] [Related]
19. Identification of CD3+CD4-CD8- T cells as potential regulatory cells in an experimental murine model of graft-versus-host skin disease (GVHD).
Miyagawa F; Okiyama N; Villarroel V; Katz SI
J Invest Dermatol; 2013 Nov; 133(11):2538-2545. PubMed ID: 23648548
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of TGF-βRII in T effector cells leads to increased resistance to TGF-β-mediated suppression of autoimmune responses in type I diabetes.
Kawamoto K; Pahuja A; Nettles A; Honkanen-Scott M; Bansal-Pakala P
Autoimmunity; 2012 Jun; 45(4):310-9. PubMed ID: 22390157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
